Higher Daily Step Counts Linked to Reduced Bradykinesia and Increased Dyskinesia

Quantifying the impact of daily movement on Parkinsonian symptoms

Parkinson disease remains a significant contributor to global disability, characterized by a progressive decline in motor function and a diverse array of non-motor symptoms [1]. While regular physical activity is critical for managing chronic conditions, patients with Parkinson disease frequently experience barriers to maintaining active lifestyles [2]. Traditional clinical assessments often fail to capture the nuances of symptom fluctuations in a patient's home environment, leading to a reliance on subjective self-reports that may lack precision [3]. Emerging research suggests that physical activity may drive neuroplasticity (the ability of the brain to reorganize its structure and functions) through the modulation of neurotrophic factors, which are proteins that support the survival and growth of neurons [4]. Wearable inertial sensors (devices that use accelerometers and gyroscopes to track movement) now offer a method to objectively quantify free-living activity and motor status over extended periods [5]. A recent cross-sectional study examines these correlations to provide a clearer picture of how daily steps influence the clinical presentation of the disease, offering physicians new insights into the relationship between mobility and symptom severity.

Objective monitoring of a diverse patient cohort

The researchers conducted a cross-sectional analysis of six weeks of data to evaluate the relationship between daily movement and symptom severity. The study included 80 participants with a mean age of 64.3 years, of whom 54 percent were male. By utilizing an extended observation period, the authors aimed to capture a stable representation of each patient's functional status and activity patterns in a real-world setting, rather than relying on a single clinical snapshot. This duration allowed for the mitigation of day-to-day variability in motor performance that often complicates the assessment of Parkinson disease.

To ensure data accuracy and eliminate the recall bias inherent in patient diaries, the study utilized the Parkinson KinetiGraph, a wrist-worn wearable sensor that monitors movement continuously. This device provided the primary metrics for the analysis, including daily physical activity assessed via step count. Motor symptom severity was evaluated using Parkinson KinetiGraph-derived bradykinesia and dyskinesia scores, which are algorithmic measurements of movement speed and involuntary movements, respectively. By employing these objective tools, the researchers were able to correlate specific activity levels with the physiological manifestations of the disease, providing clinicians with a more accurate reflection of how patients function outside the clinic.

The correlation between step counts and motor fluctuations

The participants exhibited a broad spectrum of physical activity levels during the six-week observation period. The researchers recorded a mean daily step count of 6139, though individual performance varied significantly, with a range spanning from a minimum of 46 steps to a maximum of 18,265 steps per day. These objective measurements provided a baseline to evaluate how daily movement interacts with the primary motor symptoms of Parkinson disease, specifically bradykinesia (the characteristic slowness of movement) and dyskinesia (the involuntary, erratic movements often associated with long-term dopaminergic therapy).

Statistical analysis revealed that higher levels of physical activity were moderately to strongly associated with lower bradykinesia scores (r = -0.52, P < 0.001). This inverse relationship suggests that patients who maintain higher step counts experience less severe slowness in their daily lives. However, the data also uncovered a distinct trade-off regarding involuntary movements. Higher daily step counts were simultaneously associated with higher dyskinesia levels (r = 0.56, P < 0.001), indicating that more active patients may be more prone to these motor complications.

The findings demonstrate that while increased physical activity levels are associated with reduced bradykinesia, they are also linked to an increase in mild dyskinesia. For the practicing clinician, these results highlight the complex relationship between mobility and symptom expression. The study suggests that while activity may mitigate slowness, it may also coincide with periods of increased involuntary movement. Physicians must consider this dynamic when adjusting dopaminergic medications or prescribing physical therapy to optimize functional capacity and quality of life.

Addressing non-motor symptoms and functional capacity

Beyond the primary motor fluctuations of bradykinesia and dyskinesia, the researchers evaluated the broader clinical picture of the participants by examining non-motor symptoms. These manifestations were assessed using the Non-Motor Symptoms Questionnaire (a 30-item screening tool used to identify and quantify various non-motor symptoms). This comprehensive assessment is vital for the practicing clinician, as the non-motor burden often dictates the overall complexity of patient management. The study emphasizes that people with Parkinson disease are typically less physically active than their age-matched peers, a trend that carries significant clinical consequences. Specifically, the findings reinforce that physical inactivity is associated with more severe symptoms, reduced functional capacity, and lower quality of life.

The objective data collected over the six-week period highlights the necessity of addressing sedentary behavior to preserve patient independence. While the study established a clear link between higher daily step counts and reduced bradykinesia, the authors noted that the relationship between movement and the diverse array of non-motor symptoms remains an area for further investigation. The researchers concluded that further studies should explore the relationship between physical activity and specific non-motor symptom profiles to determine if increased mobility can mitigate non-motor complications as effectively as it appears to reduce slowness of movement. For physicians, these results suggest that monitoring daily activity via wearable devices may serve as a valuable proxy for understanding a patient's functional status, allowing for more personalized and timely interventions to prevent a diminished quality of life.

References

1. Neta RDSC, Batista CDS, Palmerim ÉMM, et al. The impact of social isolation due to the COVID-19 pandemic on functional performance, fall risk, and gait in individuals with Parkinson's Disease: a systematic review.. Neuroscience. 2025. doi:10.1016/j.neuroscience.2025.08.014

2. Bull F, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. British Journal of Sports Medicine. 2020. doi:10.1136/bjsports-2020-102955

3. Li H, Cao C, Li Y. Self-directed physical activity interventions for motor symptoms and quality of life in early and mid-stage Parkinson's disease: A systematic review and meta-analysis.. Archives of gerontology and geriatrics. 2024. doi:10.1016/j.archger.2023.105159

4. Rotondo R, Proietti S, Perluigi M, et al. Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson's Disease: A systematic review and meta-analysis.. Ageing research reviews. 2023. doi:10.1016/j.arr.2023.102089

5. Sica M, Tedesco S, Crowe C, et al. Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.. PloS one. 2021. doi:10.1371/journal.pone.0246528